Loading clinical trials...
Loading clinical trials...
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Central Eastern Europe and Russia. Lung-EPICLIN
Conditions
Locations
31
Russia
Research Site
Barnaul, Altaiskiy Krai, Russia
Research Site
Birobidzhan, EAO, Russia
Research Site
Khabarovsk, Khabarovskiy Krai, Russia
Research Site
Khanty-Mansyisk, Khanty-Mansyiskyi AO, Russia
Research Site
Krasnodar, Krasnodarskiy Krai, Russia
Research Site
Vladivostok, Primorskiy Krai, Russia
Start Date
February 1, 2010
Primary Completion Date
March 1, 2011
Completion Date
March 1, 2012
Last Updated
May 19, 2015
NCT07485114
NCT06066138
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions